RxDoctor Payments Data

Dieter Lubbe, MD

Interventional Cardiology · Spokane, WANPI 1477586196

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $5,131 of the $7,346 with a category attached, or 69.8%. 7 manufacturers reported payments, led by Edwards Lifesciences at 43.0% of the total.

$7,346in general payments, 2019–2025

Across 53 payments — averaging $138.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$3K
  • Abbott$2K
  • Medtronic$2K
  • Abiomed$238
  • Shockwave Medical, Inc$109
  • Boston Scientific$31
  • plus $12 from 1 others

What the payments were for

  • Travel & lodging$5,13170%
  • Food & beverage$2,20330%
  • Education$120%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,346 in reported general payments places this provider in the 60th percentile of 125 interventional cardiology providers in Washington.

See all interventional cardiology providers in Washington

Medicare billing

Part B allowed, 2024
$174,118
Medicare patients
859
Services billed
1,597

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban115$161,716
XareltoRivaroxaban108$124,472
Repatha SureclickEvolocumab63$98,559
Praluent PenAlirocumab13$18,345
EntrestoSacubitril/Valsartan13$14,502
Ezetimibe196$4,818
Metoprolol Succinate285$2,859
Isosorbide Mononitrate ErIsosorbide Mononitrate201$2,804
Diltiazem 24hr Er (Cd)Diltiazem Hcl72$2,613
Atorvastatin Calcium189$2,181
Rosuvastatin Calcium214$2,102
Losartan Potassium195$1,910
Spironolactone149$1,465
ClopidogrelClopidogrel Bisulfate168$1,344
Furosemide158$1,214

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Spokane

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →